• Home
  • About us
  • Team
    • Management team
    • Advisory Board
  • Portfolio companies
    • Exited investments
    • Current investments
  • News
  • Contact

News

Home / News

Pipeline Therapeutics Initiates Phase 1/2a Clinical Trial of PIPE-505 in Sensorineural Hearing Loss

23.07.2020

PIPE-505 is the first small molecule developed specifically for the treatment of sensorineural hearing loss (SNHL) associated with speech-in-noise impairment

More

Potential of Imaging and the role for AI in the management of COVID-19

27.06.2020

Just published: Potential of Imaging and the role for AI in the management of COVID-19

More

IAG’s Science Team Just Published on Reporter Gene Imaging in Translational Medicine in Drug

22.04.2020

IAG’s radiomics team headed by Dr. Faiq Shaikh has just published the first article that explores the role of Reporter Gene Imaging in the realm of translational medicine.

More

Pipeline Therapeutics Completes $30 Million Series B Financing

18.12.2019

Proceeds to advance PIPE-505 in hearing loss and additional neuroregenerative programs focused on synaptogenesis, remyelination and axonal repair

More

RBV Capital announces an exit from another project, returning the full investment amount to its limited partners

05.12.2019

In 2017, RBV Capital acquired an equity stake in an innovative UK-based company developing an asset for treating symptoms of multiple sclerosis

More
Previous
Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11